期刊
JOURNAL OF CELLULAR PHYSIOLOGY
卷 235, 期 2, 页码 1247-1258出版社
WILEY
DOI: 10.1002/jcp.29040
关键词
AKT/mTOR /P70S6K; DDP; esophageal cancer; miR-10b; PPAR gamma
资金
- Key Research Project of Henan Province High Education [18A320054]
- Henan Provincial Key Science and Technology Research Project [182102310116]
- National Natural Science Foundation of China [81702971]
It is well known that the acquisition of chemoresistance is a major obstacle for the effective treatment of human cancers. It is reported that microRNAs (miRNAs) are implicated in chemotherapy resistance of various malignancies. miR-10b was previously proved as an oncogene in multiple malignancies, including esophageal cancer. However, its biological significance in regulating cisplatin (DDP) resistance in esophageal cancer is still elusive. Here, we observed that miR-10b expression was upregulated and peroxisome proliferator-activated receptor-gamma (PPAR gamma) expression was downregulated in esophageal cancer tumor tissues and cells. PPAR gamma was proved as a functional target of miR-10b. Moreover, suppression of miR-10b enhanced the chemosensitivity of esophageal cancer cells to DDP in vitro and in vivo. In addition, PPAR gamma-mediated DDP sensitivity was weakened by miR-10b overexpression. Furthermore, miR-10b-activated AKT/mTOR/p70S6K signaling pathway through targeting PPAR gamma. Inactivation of AKT/mTOR/p70S6K by AKT inhibitor (GSK690693) attenuated miR-10b-induced DDP resistance in esophageal cancer cells. Taken together these observation, miRNA-10b-mediated PPAR gamma inhibition enhanced DDP resistance by activating the AKT/mTOR/P70S6K signaling in esophageal cancer, suggesting a potential target to improve therapeutic response of patients with esophageal cancer to DDP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据